1 year return (CAGR)
18.43%
Madrigal Pharmaceuticals Inc Exchange (NASDAQ, USD)
MDGL
516.56
-9.56 (-1.80%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
43.85%
5 year return (CAGR)
45.52%
10 year return (CAGR)
47.01%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
12.06B
Price/Sales
9.39
Ent value
12.49B
Price/Book
23.03
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
54.23
EPS growth
-0.37%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 536.04 |
| Daily high | 536.04 |
| Daily low | 515.98 |
| Daily Volume | 186K |
| All-time high | 602.83 |
| 1y analyst estimate | 678.06 |
| Beta | -0.99 |
| EPS (TTM) | -11.15 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| MDGL | S&P500 | |
| Current price drop from All-time high | -14.31% | -0.84% |
| Highest price drop | -98.40% | -56.47% |
| Date of highest drop | 11 Feb 2016 | 9 Mar 2009 |
| Avg drop from high | -57.86% | -10.68% |
| Avg time to new high | 170 days | 12 days |
| Max time to new high | 3162 days | 1805 days |
News
